In the United States about 480,000 deaths/year are caused by cigarette smoking and about 50,000 due to opioid abuse. Co‐use of more than one drug is common, therefore, it is vital to study the effects of drug combinations to understand how co‐use alters the brain. Especially given that in America, > 90% of opioid dependents are heavy smokers. The objective for this study is to determine how combined nicotine + morphine alters reward‐related behavior and nicotinic acetylcholine receptor (nAChR) expression in the midbrain. Our hypothesis is that co‐use of nicotine + morphine leads to enhanced GABA neuron disinhibition of VTA dopamine neurons. Female and male (3–5 months old) C57BL/6J background strain mice with or without α4‐mCherryα6‐GFP nAChRs were used in conditioned place (CPP) preference assays to examine reward‐related behavior with nicotine + morphine. We used confocal microscopy to analyze the density of α4‐containing (α4*), α6*, and α4α6* nAChRs in ventral tegmental area (VTA), substantia nigra pars compacta (SNc), and substantia nigra pars reticulata (SNr). In our CPP assays, a Two‐way ANOVA (factors: treatment and sex) showed a significant effect of sex (F (1, 42) = 5.75; p = 0.02) on reward‐related behavior, suggesting a sex‐dependent dose effect with morphine. In our microscopy assays, nicotine + morphine treatment downregulated α4* nAChRs on SNr GABA cells. Our CPP data supports that sex is an important variable in the effects of drugs on reward‐related behavior. Our receptor regulation data suggests that downregulation of α4* nAChRs on SNr GABA cells is important to the combined effects of nicotine + morphine.Support or Funding InformationSupport: Funding was provided through start‐up funds through the Marshall University Research Corporation.
Read full abstract